AARTI DRUGS LTD.
NSE : AARTIDRUGSBSE : 524348ISIN
CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse
: Aarti
BSE733.8021.6 (+3.03 % )
PREV CLOSE (Rs.) 712.20
OPEN PRICE (Rs.) 718.25
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 66504
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE733.50 21.2 (+2.98 % )
PREV CLOSE(Rs.) 712.30
OPEN PRICE (Rs.) 714.00
BID PRICE (QTY) 733.50 (186 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 1534378
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Board Meetings
Source Date | Board Meeting Date | Details |
---|---|---|
16-Mar-2021 | 19-Mar-2021 | Buy Back of Shares |
19-Jan-2021 | 25-Jan-2021 | Quarterly Results |
20-Oct-2020 | 23-Oct-2020 | Interim Dividend & Audited Results |
19-Oct-2020 | 23-Oct-2020 | Audited Results |
17-Aug-2020 | 20-Aug-2020 | Bonus issue |
11-May-2020 | 15-May-2020 | Audited Results |
29-Jan-2020 | 06-Feb-2020 | Interim Dividend & Quarterly Results |
11-Oct-2019 | 23-Oct-2019 | AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2019 ,inter alia, to consider and approve Audited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2019. |
17-Jul-2019 | 26-Jul-2019 | Quarterly Results |
07-May-2019 | 15-May-2019 | AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2019 ,inter alia, to consider and approve This is to inform you that the next meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, May 15, 2019 inter-alia to; 1) Consider, approve and take on record Audited Financial Results for the quarter and year ended March 31, 2019. 2) Consider and recommend final dividend, if any, for the year ended March 31, 2019. |